Fortress Biotech Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights Nov 09, 2020
Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting Nov 09, 2020
Mustang Bio Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights Nov 06, 2020
Checkpoint Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights Nov 04, 2020
Fortress Biotech Announces Oral and Poster Data Presentations at the 62nd American Society of Hematology (ASH) Annual Meeting Nov 04, 2020
Mustang Bio Announces MB-106 Data Selected for Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting Nov 04, 2020
Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab Nov 02, 2020
Mustang Bio Announces Initial Phase 1 Data on MB-105 for Patients with PSCA-positive Castration Resistant Prostate Cancer Oct 26, 2020
Fortress Biotech’s Partner Company, Journey Medical Corporation, to be Featured in Webinar Hosted by ROTH Capital Partners Oct 19, 2020
